3-Chloro-6-methoxypyrazin-2-amine

Catalog No. :
ACQBNY281
CAS No. :
13484-56-5
Molecular Formula :
C5H6ClN3O
Molecular Weight :
159.58

IUPAC Name:3-chloro-6-methoxypyrazin-2-amine

3-Chloro-6-methoxypyrazin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$50.00Login to see priceIn stockIn stock
250mg95%$86.00Login to see priceIn stockIn stock
1g95%$215.00Login to see priceIn stockIn stock
5g95%$755.00Login to see priceIn stockInquiry
25g95%$2960.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Chloro-6-methoxypyrazin-2-amine
IUPAC Name3-chloro-6-methoxypyrazin-2-amine
MDL No.MFCD20691296
Molecular FormulaC5H6ClN3O
Molecular Weight159.58
SMILESNC1=NC(OC)=CN=C1Cl
InChI KeyNXASRWBWVZXWCY-UHFFFAOYSA-N
SynonymCS-0150237 | C72387 | SCHEMBL4136927 | SB12255 | DS-5829 | NXASRWBWVZXWCY-UHFFFAOYSA-N | Pyrazinamine, 3-chloro-6-methoxy- | 3-Chloro-6-methoxypyrazin-2-amine | DTXSID10470790 | 2-Amino-3-chloro-6-methoxypyrazine | AKOS022172224 | MFCD20691296 | A900944
CAS No.13484-56-5
PubChem CID11701087

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P280

Synthetic Route by SureRoute

1. ACQBNY281 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEZKI514 route compound structure diagram
    ACEZKI5146905-47-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQBNY281 route product structure diagram
    ACQBNY28113484-56-5 In Stock
Inquiry

2. ACQBNY281 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQBNY281 route product structure diagram
    ACQBNY28113484-56-5 In Stock
Inquiry

Comments (0)